Aresa has established two operational subsidiaries in Balkan to acquire and start clearing landmine infected areas

First North announcement # 11, 2008
Copenhagen, July 4, 2008


Aresa has established two operational subsidiaries in Balkan to acquire and
start clearing landmine infected areas 

During this week the two newly established subsidiaries in Croatia and Serbia,
respectively, have become operational. The objective for the two subsidiaries
is to engage in projects clearing landmines and ammunition in the two
countries, as it has previously been communicated in First North announcements
#3 and #8. 

In collaboration with regional stakeholders and local companies, it is planned
to invest an amount up to DKK 5 mill. in mine infected areas and to start the
clearing of the mines during 2008. The areas will be carefully selected with
focus on the socio-economic potential for the local community, when the
landmines have been cleared.	 

”We intend to start clearing more than 500.000 m2 during 2008, corresponding to
500 plots for family houses or 5% of the total cleared area in Croatia in
2006”, says Steen Thaarup, CEO of Aresa. 

”There are many interesting economical perspectives in acquiring un-productive
areas, to be cleared and remediated into productivity again”, says Kim
Bretting, who has been appointed as director for the two subsidiaries, and he
continues: ”the most important however, is we can increase the area of arable
land including creating a number of jobs directly and indirectly”. 

The content of this message is not expected to have impact on the result for the
current financial year.

For more information, please contact 

Steen Thaarup
CEO

Phone: +45 7022 7747
Mobile: +45 4077 8695
E-mail: st@aresa.dk

The company's certified advisor is Dahl-Sørensen & Partners A/S, Allan Reimann,
tel.: +45 3364 9205. 


About Aresa
Aresa is a plant biotech company established in 2001 by the company's current
CSO, Carsten Meier. It originates from the Institute of Molecular Biology at
Copenhagen University. 

Aresa focuses on the plant-based technology platform: BioSensor for the
detection of substances in soil, including leakage of explosives from
landmines. 

Aresa shares are traded at the Nasdaq/OMX-First North stock exchange since the
introduction in 2006. Aresa is based at Symbion Science Park in Copenhagen and
has greenhouse facilities on the outskirts of Copenhagen and test sites in
Denmark, Croatia, and Serbia. Aresa has 11 employees, 7 in research &
development and 2 in landmine operations.